Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764521 | 12676452 | 1 | I | 20160818 | 20160823 | 20160823 | EXP | CA-AMGEN-CANSP2016109094 | AMGEN | 62.00 | YR | A | F | Y | 0.00000 | 20160823 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126764521 | 12676452 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126764521 | 12676452 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126764521 | 12676452 | 4 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 5 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 7 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 8 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 9 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126764521 | 12676452 | 10 | SS | SODIUM AUROTHIOMALATE | GOLD SODIUM THIOMALATE | 1 | Intramuscular | UNK | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126764521 | 12676452 | 1 | Product used for unknown indication |
| 126764521 | 12676452 | 2 | Product used for unknown indication |
| 126764521 | 12676452 | 3 | Product used for unknown indication |
| 126764521 | 12676452 | 4 | Product used for unknown indication |
| 126764521 | 12676452 | 5 | Product used for unknown indication |
| 126764521 | 12676452 | 6 | Product used for unknown indication |
| 126764521 | 12676452 | 7 | Product used for unknown indication |
| 126764521 | 12676452 | 8 | Product used for unknown indication |
| 126764521 | 12676452 | 9 | Product used for unknown indication |
| 126764521 | 12676452 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126764521 | 12676452 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126764521 | 12676452 | Demyelination | |
| 126764521 | 12676452 | Diabetes mellitus | |
| 126764521 | 12676452 | Drug hypersensitivity | |
| 126764521 | 12676452 | Impaired gastric emptying | |
| 126764521 | 12676452 | Renal impairment | |
| 126764521 | 12676452 | Rheumatoid arthritis | |
| 126764521 | 12676452 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |